165 related articles for article (PubMed ID: 18607348)
21. Propyl gallate plays a nephroprotective role in early stage of diabetic nephropathy associated with suppression of glomerular endothelial cell proliferation and angiogenesis.
Tian S; Tang J; Liu H; Wang L; Shen J; Li J; Gan Y
Exp Diabetes Res; 2012; 2012():209567. PubMed ID: 22988451
[TBL] [Abstract][Full Text] [Related]
22. Klotho attenuates renal hypertrophy and glomerular injury in Ins2Akita diabetic mice.
Kadoya H; Satoh M; Haruna Y; Sasaki T; Kashihara N
Clin Exp Nephrol; 2016 Oct; 20(5):671-678. PubMed ID: 26586006
[TBL] [Abstract][Full Text] [Related]
23. Protective effects of adiponectin on uncoupling of glomerular VEGF-NO axis in early streptozotocin-induced type 2 diabetic rats.
Hou N; Huang N; Han F; Zhao J; Liu X; Sun X
Int Urol Nephrol; 2014 Oct; 46(10):2045-51. PubMed ID: 25118612
[TBL] [Abstract][Full Text] [Related]
24. Chronic hypoxia exacerbates diabetic glomerulosclerosis through mesangiolysis and podocyte injury in db/db mice.
Takahashi N; Yoshida H; Kimura H; Kamiyama K; Kurose T; Sugimoto H; Imura T; Yokoi S; Mikami D; Kasuno K; Kurosawa H; Hirayama Y; Naiki H; Hara M; Iwano M
Nephrol Dial Transplant; 2020 Oct; 35(10):1678-1688. PubMed ID: 32596728
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of calmodulin in pancreatic beta cells induces diabetic nephropathy.
Yuzawa Y; Niki I; Kosugi T; Maruyama S; Yoshida F; Takeda M; Tagawa Y; Kaneko Y; Kimura T; Kato N; Yamamoto J; Sato W; Nakagawa T; Matsuo S
J Am Soc Nephrol; 2008 Sep; 19(9):1701-11. PubMed ID: 18525005
[TBL] [Abstract][Full Text] [Related]
26. Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse.
Tanabe K; Lanaspa MA; Kitagawa W; Rivard CJ; Miyazaki M; Klawitter J; Schreiner GF; Saleem MA; Mathieson PW; Makino H; Johnson RJ; Nakagawa T
Am J Physiol Renal Physiol; 2012 May; 302(9):F1151-60. PubMed ID: 22338086
[TBL] [Abstract][Full Text] [Related]
27. Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model.
Wang XX; Jiang T; Shen Y; Caldas Y; Miyazaki-Anzai S; Santamaria H; Urbanek C; Solis N; Scherzer P; Lewis L; Gonzalez FJ; Adorini L; Pruzanski M; Kopp JB; Verlander JW; Levi M
Diabetes; 2010 Nov; 59(11):2916-27. PubMed ID: 20699418
[TBL] [Abstract][Full Text] [Related]
28. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes.
Vriese AS; Tilton RG; Elger M; Stephan CC; Kriz W; Lameire NH
J Am Soc Nephrol; 2001 May; 12(5):993-1000. PubMed ID: 11316858
[TBL] [Abstract][Full Text] [Related]
29. Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.
Yamamoto Y; Maeshima Y; Kitayama H; Kitamura S; Takazawa Y; Sugiyama H; Yamasaki Y; Makino H
Diabetes; 2004 Jul; 53(7):1831-40. PubMed ID: 15220208
[TBL] [Abstract][Full Text] [Related]
30. Low nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression.
Miyazawa T; Zeng F; Wang S; Fan X; Cheng H; Yang H; Bian A; Fogo AB; Harris RC
Kidney Int; 2013 Dec; 84(6):1176-88. PubMed ID: 23760291
[TBL] [Abstract][Full Text] [Related]
31. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.
Chow F; Ozols E; Nikolic-Paterson DJ; Atkins RC; Tesch GH
Kidney Int; 2004 Jan; 65(1):116-28. PubMed ID: 14675042
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor (VEGF) and VEGF receptors in diabetic nephropathy: expression studies in biopsies of type 2 diabetic patients.
Bortoloso E; Del Prete D; Gambaro G; Dalla Vestra M; Sailer A; Baggio B; Antonucci F; Fioretto P; Anglani F
Ren Fail; 2001; 23(3-4):483-93. PubMed ID: 11499563
[TBL] [Abstract][Full Text] [Related]
33. Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes.
Veron D; Bertuccio CA; Marlier A; Reidy K; Garcia AM; Jimenez J; Velazquez H; Kashgarian M; Moeckel GW; Tufro A
Diabetologia; 2011 May; 54(5):1227-41. PubMed ID: 21318407
[TBL] [Abstract][Full Text] [Related]
34. Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.
Hohenstein B; Hausknecht B; Boehmer K; Riess R; Brekken RA; Hugo CP
Kidney Int; 2006 May; 69(9):1654-61. PubMed ID: 16541023
[TBL] [Abstract][Full Text] [Related]
35. Reduced Glomerular Endothelial Thrombomodulin Is Associated with Glomerular Macrophage Infiltration in Diabetic Nephropathy.
van Aanhold CCL; Dijkstra KL; Bos M; Wolterbeek R; van den Berg BM; Bruijn JA; Bajema IM; Baelde HJ
Am J Pathol; 2021 May; 191(5):829-837. PubMed ID: 33617784
[TBL] [Abstract][Full Text] [Related]
36. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
Ichinose K; Maeshima Y; Yamamoto Y; Kitayama H; Takazawa Y; Hirokoshi K; Sugiyama H; Yamasaki Y; Eguchi K; Makino H
Diabetes; 2005 Oct; 54(10):2891-903. PubMed ID: 16186390
[TBL] [Abstract][Full Text] [Related]
37. Exacerbation of diabetic renal alterations in mice lacking vasohibin-1.
Hinamoto N; Maeshima Y; Yamasaki H; Nasu T; Saito D; Watatani H; Ujike H; Tanabe K; Masuda K; Arata Y; Sugiyama H; Sato Y; Makino H
PLoS One; 2014; 9(9):e107934. PubMed ID: 25255225
[TBL] [Abstract][Full Text] [Related]
38. Endoglin Mediates Vascular Endothelial Growth Factor-A-Induced Endothelial Cell Activation by Regulating Akt Signaling.
Bus P; Gerrits T; Heemskerk SAC; Zandbergen M; Wolterbeek R; Bruijn JA; Baelde HJ; Scharpfenecker M
Am J Pathol; 2018 Dec; 188(12):2924-2935. PubMed ID: 30248336
[TBL] [Abstract][Full Text] [Related]
39. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS
Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198
[TBL] [Abstract][Full Text] [Related]
40. ENOS deficiency causes podocyte injury with mitochondrial abnormality.
Ueda S; Ozawa S; Mori K; Asanuma K; Yanagita M; Uchida S; Nakagawa T
Free Radic Biol Med; 2015 Oct; 87():181-92. PubMed ID: 26119782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
